Article
CYP26B1-related disorder: expanding the ends of the spectrum through clinical and molecular evidence
27 Sept 2023
Abstract excerpt
CYP26B1 metabolizes retinoic acid in the developing embryo to regulate its levels. A limited number of individuals with pathogenic variants in CYP26B1 have been documented with a varied phenotypic spectrum, spanning from a severe manifestation involving skull anomalies, craniosynostosis, encephalocele, radio-humeral fusion, oligodactyly, and a narrow thorax, to a milder presentation characterized by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
